Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vardenafil in Raynaud's Syndrome
NCT01291199Phase 3Completed
- Sponsor
- University of Cologne
- Start
- Nov 2006
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vardenafil in Raynaud phenomenon, sponsored by University of Cologne. Started Nov 2006; status: completed.
02
Drugs
vardenafil
03
Conditions
Raynaud phenomenon
Beyond the preview
Go deeper on NCT01291199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01291199.